Literature DB >> 1483043

The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies.

T R Helliwell1, N T Man, G E Morris, K E Davies.   

Abstract

Utrophin is the 400 kDa protein product of an autosomal homologue (DMDL) of the dystrophin gene. In normal skeletal muscle, utrophin is expressed in vascular smooth muscle, endothelium and nerves but not in mature muscle fibres except at the neuromuscular junction. We have examined the expression of utrophin in a wide range of human skeletal muscle diseases using monoclonal antibodies against three C-terminal epitopes. Utrophin is consistently expressed in all basophilic, regenerating fibres irrespective of the underlying disease or expression of dystrophin. It is also found in regenerating fibres from a normal volunteer. In Duchenne and Becker dystrophies, as well as in dermatomyositis, sarcolemmal staining for utrophin is also seen in larger fibres which are not obviously regenerating. These studies do not support the idea that utrophin occupies membrane attachment sites only when dystrophin is absent or reduced, but would be consistent with utrophin expression as part of an activated foetal programme during regeneration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483043     DOI: 10.1016/0960-8966(92)90004-p

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  41 in total

1.  Sparing of the extraocular muscles in mdx mice with absent or reduced utrophin expression: A life span analysis.

Authors:  Abby A McDonald; Sadie L Hebert; Linda K McLoon
Journal:  Neuromuscul Disord       Date:  2015-09-06       Impact factor: 4.296

2.  Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice.

Authors:  Alison R Amenta; Atilgan Yilmaz; Sasha Bogdanovich; Beth A McKechnie; Mehrdad Abedi; Tejvir S Khurana; Justin R Fallon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

3.  Increased expression of dystrophin, beta-dystroglycan and adhalin in denervated rat muscles.

Authors:  D Biral; L Senter; G Salviati
Journal:  J Muscle Res Cell Motil       Date:  1996-10       Impact factor: 2.698

Review 4.  Satellite Cells in Muscular Dystrophy - Lost in Polarity.

Authors:  Natasha C Chang; Fabien P Chevalier; Michael A Rudnicki
Journal:  Trends Mol Med       Date:  2016-05-05       Impact factor: 11.951

5.  2015 William Allan Award.

Authors:  Kay E Davies
Journal:  Am J Hum Genet       Date:  2016-03-03       Impact factor: 11.025

Review 6.  Mechanisms of resistance to pathogenesis in muscular dystrophies.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

Review 7.  What is the level of dystrophin expression required for effective therapy of Duchenne muscular dystrophy?

Authors:  Dominic J Wells
Journal:  J Muscle Res Cell Motil       Date:  2019-07-09       Impact factor: 2.698

8.  The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy.

Authors:  K J Perkins; E A Burton; K E Davies
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

9.  Molecular and functional analysis of the utrophin promoter.

Authors:  C L Dennis; J M Tinsley; A E Deconinck; K E Davies
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

Review 10.  Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.

Authors:  Kristin Wilson; Crystal Faelan; Janet C Patterson-Kane; Daniel G Rudmann; Steven A Moore; Diane Frank; Jay Charleston; Jon Tinsley; G David Young; Anthony J Milici
Journal:  Toxicol Pathol       Date:  2017-10-03       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.